KKR & Co. Inc. (NYSE:KKR) entered into definitive agreements with CVC, a private markets manager, to become the largest ...

US-based investment company KKR has agreed to acquire a stake of up to 54% in Healthcare Global Enterprises (HCG), an ...

The group will purchase up to 54% of HCG’s equity at $5.14 (INR 445) per share. Global investment firm KKR has signed ...

KKR & Co Inc. is set to acquire a majority stake in India’s Healthcare Global Enterprises Ltd. from CVC Capital Partners at a ...

KKR acquires a controlling stake in Healthcare Global from CVC Capital Partners for Rs 3466 crore, strengthening its presence ...

智通财经APP获悉，私募股权巨头KKR(KKR.US)将以4亿美元的价格从CVC Capital Partners手中收购印度Healthcare Global Enterprises ...

KKR will purchase HCG shares at Rs 445 per share and make an open offer for the company's shareholders to buy an additional ...

私募巨头KKR（KKR.US）宣布以4亿美元的价格收购印度Healthcare Global Enterprises Ltd.（HCG）多数股权，成为其最大股东与唯一运营商。HCG在声明中表示，KKR将以每股445卢比的价格从CVC Capital Partners手中购买至多54%的股权，随后还将向公众股东公开收购更多股票，最终可能使KKR持有多达77%的股份，全面掌控HCG在印度的业务。

KKR has agreed to acquire a majority stake in Healthcare Global Enterprises, an India-based oncology hospital chain, for $400 million. The seller is CVC Capital Partners. Dr. BS Ajaikumar, founder of ...

观点网讯：2月24日，市场消息显示，私募股权巨头KKR（KKR.US）宣布斥资4亿美元收购印度癌症护理服务商HCG的多数股权，成为其最大股东和唯一运营商。 此次交易中，KKR将以每股445卢比的价格从CVC Capital Partners手中收购至多54%的HCG股权，并可能通过公开市场向公众股东购买更多股份，最终持有至多77%的HCG股份，实现对HCG在印度业务的全权控制。

US private equity firm KKR & Co. will acquire a majority stake in HealthCare Global Enterprises Ltd. for around Rs 3,350 ...

Global investment firm KKR has agreed to acquire a controlling stake in Bengaluru-based Healthcare Global Enterprises (HCG) ...